Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
22.69
+1.05 (4.85%)
Nov 20, 2024, 4:00 PM EST - Market closed
Arvinas Employees
Arvinas had 445 employees as of December 31, 2023. The number of employees increased by 30 or 7.23% compared to the previous year.
Employees
445
Change (1Y)
30
Growth (1Y)
7.23%
Revenue / Employee
$362,022
Profits / Employee
-$693,483
Market Cap
1.56B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Teladoc Health | 5,600 |
Certara | 1,391 |
InMode | 581 |
BioCryst Pharmaceuticals | 536 |
Intellia Therapeutics | 526 |
Dynavax Technologies | 408 |
Travere Therapeutics | 380 |
Kiniksa Pharmaceuticals International, | 297 |
ARVN News
- 20 hours ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Arvinas, Inc. (ARVN) And Encourages Stockholders to Reach Out - Accesswire
- 16 days ago - Arvinas to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 21 days ago - Arvinas, Inc. (ARVN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Arvinas Gives Back to Local Greater New Haven Community in Third Annual Impact Day - GlobeNewsWire
- 4 weeks ago - Arvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024 - GlobeNewsWire
- 4 months ago - Undercovered Dozen: Spirit Airlines, HubSpot, Cigna, First Quantum Minerals + - Seeking Alpha
- 5 months ago - Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer - GlobeNewsWire